BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 830405)

  • 1. In vivo tumour-cell proliferation after adriamycin treatment.
    Rowley R; Hopkins HA; Looney WB
    Br J Cancer; 1982 Mar; 45(3):429-37. PubMed ID: 7073936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytostatic effects in osteosarcomas as detected by flow cytometric DNA analysis after preoperative chemotherapy according to the COSS 80/82 protocol.
    Bösing T; Roessner A; Hiddemann W; Mellin W; Grundmann E
    J Cancer Res Clin Oncol; 1987; 113(4):369-75. PubMed ID: 3474234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response kinetics of host and experimental solid tumour after adriamycin.
    Hopkins HA; Looney WB; Teja K; Hobson AS; MacLeod MS
    Br J Cancer; 1978 Jun; 37(6):1006-14. PubMed ID: 209806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic drugs: clinical pharmacology and therapeutic use.
    Bender RA; Zwelling LA; Doroshow JH; Locker GY; Hande KR; Murinson DS; Cohen M; Myers CE; Chabner BA
    Drugs; 1978 Jul; 16(1):46-87. PubMed ID: 78795
    [No Abstract]   [Full Text] [Related]  

  • 5. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
    Swenson DH; Lin JK; Miller EC; Miller JA
    Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse.
    Tobey RA
    Cancer Res; 1972 Dec; 32(12):2720-5. PubMed ID: 4118765
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.
    Barranco SC; Novak JK
    Cancer Res; 1974 Jul; 34(7):1616-8. PubMed ID: 4858112
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA replication in Syrian hamster cells transiently exposed to hydroxyurea.
    Creasey DC; Ts'o PO
    Cancer Res; 1988 Nov; 48(22):6298-302. PubMed ID: 3180047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adriamycin and radiation on G2 progression.
    Kimler BF; Leeper DB
    Cancer Res; 1976 Sep; 36(9 pt.1):3212-6. PubMed ID: 975085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of adriamycin on cell cycle progression and DNA replication in chinese hamster ovary cells.
    Clarkson JM; Humphrey RM
    Cancer Res; 1977 Jan; 37(1):200-5. PubMed ID: 830405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular effects of adriamycin on dividing and nondividing cells.
    Barranco SC
    Pharmacol Ther; 1984; 24(3):303-19. PubMed ID: 6379686
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin.
    IARC Monogr Eval Carcinog Risk Chem Man; 1976; 10():43-9. PubMed ID: 791807
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.